GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seelos Therapeutics Inc (STU:NXE0) » Definitions » E10

Seelos Therapeutics (STU:NXE0) E10 : €-40,693.00 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Seelos Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Seelos Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was €-1.472. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-40,693.00 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 30.30% per year. During the past 5 years, the average E10 Growth Rate was 34.60% per year. During the past 10 years, the average E10 Growth Rate was 25.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Seelos Therapeutics was 35.80% per year. The lowest was 9.30% per year. And the median was 24.70% per year.

As of today (2024-06-07), Seelos Therapeutics's current stock price is €21.24. Seelos Therapeutics's E10 for the quarter that ended in Mar. 2024 was €-40,693.00. Seelos Therapeutics's Shiller PE Ratio of today is .


Seelos Therapeutics E10 Historical Data

The historical data trend for Seelos Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seelos Therapeutics E10 Chart

Seelos Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -44,739.90 -21,986.80 -20,335.50 -13,349.80 -18,532.80

Seelos Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10,552.90 -9,861.43 -9,151.13 -18,532.80 -40,693.00

Competitive Comparison of Seelos Therapeutics's E10

For the Biotechnology subindustry, Seelos Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Seelos Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Seelos Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Seelos Therapeutics's Shiller PE Ratio falls into.



Seelos Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Seelos Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.472/131.7762*131.7762
=-1.472

Current CPI (Mar. 2024) = 131.7762.

Seelos Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201406 2,611.475 100.560 3,422.156
201409 -4,469.807 100.428 -5,865.051
201412 -23,357.043 99.070 -31,068.050
201503 -8,463.840 99.621 -11,195.747
201506 -6,676.138 100.684 -8,737.803
201509 -6,407.564 100.392 -8,410.716
201512 -3,058.253 99.792 -4,038.433
201603 -2,621.783 100.470 -3,438.710
201606 -3,458.460 101.688 -4,481.770
201609 -1,071.027 101.861 -1,385.573
201612 -263.921 101.863 -341.425
201703 7,001.345 102.862 8,969.385
201706 -833.048 103.349 -1,062.185
201709 -1,751.849 104.136 -2,216.840
201712 -1,417.749 104.011 -1,796.208
201803 -817.496 105.290 -1,023.146
201806 -616.326 106.317 -763.916
201809 -74.045 106.507 -91.613
201812 -1,565.525 105.998 -1,946.255
201903 -845.352 107.251 -1,038.664
201906 -19.116 108.070 -23.309
201909 -28.330 108.329 -34.462
201912 -85.183 108.420 -103.533
202003 -30.408 108.902 -36.795
202006 -17.050 108.767 -20.657
202009 -18.338 109.815 -22.005
202012 -25.646 109.897 -30.752
202103 -56.448 111.754 -66.561
202106 -19.920 114.631 -22.899
202109 -22.440 115.734 -25.550
202112 -59.472 117.630 -66.624
202203 -28.330 121.301 -30.776
202206 -45.408 125.017 -47.863
202209 -43.632 125.227 -45.914
202212 -38.817 125.222 -40.849
202303 -26.750 127.348 -27.680
202306 -48.734 128.729 -49.888
202309 -26.986 129.860 -27.384
202312 0.514 129.419 0.523
202403 -1.472 131.776 -1.472

Add all the adjusted EPS together and divide 10 will get our e10.


Seelos Therapeutics  (STU:NXE0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Seelos Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Seelos Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Seelos Therapeutics (STU:NXE0) Business Description

Traded in Other Exchanges
Address
300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.

Seelos Therapeutics (STU:NXE0) Headlines

No Headlines